Skip Nav Destination
IN THIS ISSUE
Modelling of a targeted nanotherapeutic ‘stroma’ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson’s disease
Jing-Wei Zhao,Sean C. Dyson,Christina Kriegel,Pam Tyers,Xiaoling He,Tarek M. Fahmy,Su M. Metcalfe,Roger A. Barker
Novel and known transcriptional targets of ALS/FTD protein TDP-43: Meta-analysis and interactive graphical database
Maize C. Cao, Emma L. Scotter
A phenotypic rescue approach identifies lineage regionalization defects in a mouse model of DiGeorge syndrome
Gabriella Lania, Monica Franzese et al.
Ilaria Gregorio, Maddalena Mereu et al.
Fate mapping melanoma persister cells through regression and into recurrent disease in adult zebrafish
Jana Travnickova, Sarah Muise et al.
The motor neuron disease mouse model hSOD1-G93A shows a non-canonical profile of senescence biomarkers
Pascual Torres, Carlos Anerillas et al.